Healthcare - Drug Manufacturers - Specialty & Generic - NYSE - US
$ 13.98
-0.427 %
$ 6.91 B
Market Cap
34.1
P/E
BALANCE SHEET
14.4 B
ASSETS
8.14 B
LIABILITIES
6.22 B
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
Elanco Animal Health Incorporated
| Current Assets | 3.41 B |
| Cash & Short-Term Investments | 352 M |
| Receivables | 1.01 B |
| Other Current Assets | 2.04 B |
| Non-Current Assets | 11 B |
| Long-Term Investments | 26 M |
| PP&E | 1.03 B |
| Other Non-Current Assets | 9.9 B |
| Current Liabilities | 1.24 B |
| Accounts Payable | 270 M |
| Short-Term Debt | 38 M |
| Other Current Liabilities | 933 M |
| Non-Current Liabilities | 6.9 B |
| Long-Term Debt | 5.85 B |
| Other Non-Current Liabilities | 1.05 B |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | ||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Cash & Cash Equivalents | 352.0 | 345.0 | 638.0 | 494.7 | 334.0 | 474.8 | 323.4 | 258.8 | |
| Short Term Investments | 0 | 14.0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Receivables | 1 010.0 | 1 002.0 | 1 028.0 | 1 076.7 | 889.9 | 709.4 | 601.9 | 630.7 | |
| Inventory | 1 735.0 | 1 538.0 | 1 373.0 | 1 578.1 | 1 050.7 | 1 004.1 | 1 062.3 | 875.6 | |
| Other Current Assets | 310.0 | 394.0 | 325.0 | 267.0 | 98.5 | 316.6 | 136.1 | 182.3 | |
| Total Current Assets | 3 407.0 | 3 279.0 | 3 276.0 | 3 416.5 | 2 373.1 | 2 504.9 | 2 123.7 | 1 947.4 | |
| PP&E | 1 026.0 | 999.0 | 1 061.0 | 1 316.3 | 955.3 | 922.4 | 920.3 | 741.8 | |
| Intangible Assets | 4 494.0 | 4 842.0 | 5 587.0 | 6 387.3 | 2 482.8 | 2 453.0 | 2 672.8 | 2 621.0 | |
| Goodwill | 5 094.0 | 5 993.0 | 6 172.0 | 6 224.8 | 2 989.6 | 2 958.0 | 2 969.2 | 2 576.5 | |
| Long Term Investments | 26.0 | 37.0 | 30.0 | 35.7 | 21.1 | 15.3 | 12.3 | 9.0 | |
| Other Long Term Assets | 315.0 | 378.0 | 387.0 | 347.8 | 185.0 | 103.1 | 242.0 | 204.0 | |
| Other Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Total Assets | 14 362.0 | 15 491.0 | 16 483.0 | 17 692.7 | 8 985.8 | 8 956.7 | 8 940.3 | 8 099.7 | |
| LIABILITIES | |||||||||
| Accounts Payable | 270.0 | 390.0 | 416.0 | 501.0 | 222.6 | 205.2 | 203.8 | 228.2 | |
| Short Term Debt | 38.0 | 388.0 | 328.0 | 591.5 | 24.5 | 29.0 | 0 | 0 | |
| Other Current Liabilities | 933.0 | 924.0 | 903.0 | 983.8 | 571.4 | 736.5 | 424.0 | 383.2 | |
| Total Current Liabilities | 1 241.0 | 1 702.0 | 1 643.0 | 2 076.3 | 818.5 | 970.7 | 632.6 | 618.9 | |
| Long Term Debt | 5 846.0 | 5 559.0 | 6 152.0 | 5 572.4 | 2 392.2 | 2 443.3 | 0 | 0 | |
| Deferred Tax Income | 567.0 | 662.0 | 745.0 | 900.3 | 100.8 | 114.6 | 251.9 | 227.5 | |
| Other Liabilities | 485.0 | 279.0 | 406.0 | 1 568.1 | 127.4 | 230.6 | 265.0 | 225.4 | |
| Total Liabilities | 8 139.0 | 8 202.0 | 8 945.0 | 9 216.8 | 3 438.9 | 3 759.2 | 1 149.5 | 1 071.8 | |
| EQUITY | |||||||||
| Common Stock | 0 | 0 | 0 | 0 | 0 | 0 | 8 047.4 | 7 484.8 | |
| Retained Earnings | (2 288.0) | (1 057.0) | (949.0) | (477.2) | 84.3 | 16.4 | 0 | 0 | |
| Other Accumulative Comprehensive Income/Loss | (266.0) | (392.0) | (209.0) | 303.0 | (173.7) | (222.2) | (256.6) | (456.9) | |
| Total Equity | 6 223.0 | 7 289.0 | 7 538.0 | 8 475.9 | 5 546.9 | 5 197.5 | 7 790.8 | 7 027.9 | |
| Total Liabilities and Equity | 14 362.0 | 15 491.0 | 16 483.0 | 17 692.7 | 8 985.8 | 8 956.7 | 8 940.3 | 8 099.7 | |
| SHARES OUTSTANDING | |||||||||
| Common Shares Outstanding | 492.3 | 488.3 | 487.2 | 441.4 | 369.0 | 313.7 | 356.2 | 356.2 | 356.2 |